Inactive

Diagnostics and Countermeasures Branch (DCB) to acquire the Panther Fusion open access platform for the clinical Panther system currently deployed within DCB and implement Hologic pan-coronavirus (OC4... Diagnostics and Countermeasures Branch (DCB) to acquire the Panther Fusion open access platform for the clinical Panther system currently deployed within DCB and implement Hologic pan-coronavirus (OC43, HKU1, NC63, 229E) and Gen Probe SARS-CoV-2 EUA assays. The Panther Fusion open access platform is a high-throughput platform technology that can be implemented for rapid coronavirus detection, Hologic pan-coronavirus (OC43, HKU1, NC63, 229E) and Gen Probe SARS-CoV-2 EUA assays.